References
- Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol 2017;13:578–92.
- Soriano A, Muratore F, Pipitone N, Boiardi L, Cimino L, Salvarani C. Visual loss and other cranial ischaemic complications in giant cell arteritis. Nat Rev Rheumatol 2017;13:476–84.
- Badakere A, Patil-Chhablani P. Orbital apex syndrome: a review. Eye Brain 2019;11:63–72.
- Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Care Res 2005;53:293–7.
- Nesher G, Berkun Y, Mates M, Baras M, Nesher R, Rubinow A, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004;83:114–22.
- van der Geest KSM, Sandovici M, van Sleen Y, Sanders JS, Bos NA, Abdulahad WH, et al. Review: what is the current evidence for disease subsets in giant cell arteritis? Arthritis Rheumatol 2018;70:1366–76.
- Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess (Rockv) 2016;20:1–270.
- Singh R, Rajakulenthiran T, Sethuge Silva RA. Acute visual loss without concurrent headaches due to ultrasound-negative, biopsy-proven giant cell arteritis. Clin Med (Lond) 2020;20:s58.
- Poudel P, Swe T, Wiilliams M, Bonilla E. Fever as the sole presentation of giant cell arteritis: a near miss. J Investig Med High Impact Case Rep 2019;7:0–3.
- Kutty RK, Maekawa M, Kawase T, Fujii N, Kato Y. Temporal arteritis with focal pachymeningitis: a deceptive association. Nagoya J Med Sci 2020;82:143–50.